Alkem Labs receives 4 Form 483 observations from USFDA
Alkem Labs receives 4 Form 483 observations from USFDA

Alkem Labs receives 4 Form 483 observations from USFDA

DSIJ Intelligence Article rating: 3.0

Alkem Laboratories (Alkem Labs) has received four observations from USFDA at its manufacturing facility located at St. Louis, Fen ton Park, USA. Inspite of this development, the stock of Alkem Labs is trading higher by a per cent on the BSE.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 3.3

Overall volumes in futures & options currently stand at 1,62,40,011 contracts with a turnover of Rs. 10,43,153.98 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 5.0

Overall volumes in futures & options currently stand at 1,62,40,011 contracts with a turnover of Rs. 10,43,153.98 crore.

Index trend and stocks in action August 26, 2019
Index trend and stocks in action August 26, 2019

Index trend and stocks in action August 26, 2019

DSIJ Intelligence-3 Article rating: 5.0

The last week’s panic low of 10,637 would be a crucial support level and, on the upside, immediate resistance is seen around the big round number i.e. 11,000 level. Stocks in news: Ipca Laboratories, Adani Ports, Bandhan Bank, Alkem Laboratories, NCL Industries, Cupid.

FM gives booster dose to revive economy
FM gives booster dose to revive economy

FM gives booster dose to revive economy

DSIJ Intelligence Article rating: 4.2

In a very comprehensive and focused approach FM Nirmala Sitharaman has announced measures that will help the economy and the market to revive.

Prime Focus nosedives on VFX business sale
Prime Focus nosedives on VFX business sale

Prime Focus nosedives on VFX business sale

DSIJ Intelligence Article rating: 3.0

Shares of Prime Focus nosedived more than 4 percent to hit 52-week low of Rs. 31.75 on Friday after the company received board approval for the sale of VFX business.

RSS
First33083309331033113313331533163317Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR